ipilimumab,lefitolimod
bms
['ipilimumab']
the combination of high subcutaneous doses or intra-tumoral administration of lefitolimod in combination with ipilimumab is safe and well tolerated in patients with advanced cancers, with preliminary antitumor activity observed. #asco23 #asco2023 #news 
Biomedical Science that Inspires. #medicine #medtwitter #meded #Science #Research #Technology #News